Skip to content

A Nutritional Intervention for Migraines

A Nutritional Intervention for Migraines

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01547494
Enrollment
16
Registered
2012-03-07
Start date
2011-09-30
Completion date
2012-10-31
Last updated
2013-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraines

Keywords

Migraines, Diet, Vegetarian, Diet, Fat-Restricted, Pain

Brief summary

The purpose of the study is to assess whether, in individuals with migraines, a low-fat, vegan diet improves pain more effectively than a control supplement or a placebo. The principal measures are pain as measured by Visual Analog Scale (VAS) and the change in migraines frequency. The study duration is 36 weeks.

Detailed description

Preliminary evidence suggests that low-fat, vegetarian diets and certain nutritional supplements can help reduce pain and also reduce the need for pain medications for some people. We will ask about 100 people to participate. All of them will get a low-fat, vegan diet and a nutritional supplement (mixture of omega-3 oils and vitamin E or a placebo), although some will get the diet first, and others will get the supplement first. This order in which they will get the diet and the supplement will be determined randomly, that is, by chance (like the toss of a coin). The principal measures are pain as measured by Visual Analog Scale (VAS)and the change in migraines frequency.

Interventions

OTHERVegan Diet

Vegan diet, which is devoid of animal products and minimal in fat

DIETARY_SUPPLEMENTmixture of omega3 and vitamins

mixture of omega3 and vitamins

Sponsors

Physicians Committee for Responsible Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. A diagnosis of migraine, as defined by the criteria of the second edition of the International Classification of Headache Disorders18 * At least 5 attacks fulfilling criteria the criteria below * Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) * Headache has at least two of the following characteristics: * unilateral location * pulsating quality * moderate or severe pain intensity * aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs) * During headache at least one of the following: * nausea and/or vomiting * photophobia and phonophobia * Not attributed to another disorder 2. Migraines occurring at least twice per month, on average. 3. Age at least 18 years 4. Ability and willingness to participate in all components of the study 5. Willingness to be assigned to either the diet group or supplement group 6. Migraine medications unchanged within last 6 weeks.

Exclusion criteria

1. \< 18 years of age 2. Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use 3. Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion) 4. Pregnancy 5. Unstable medical or psychiatric illness 6. Likely to be disruptive in group sessions (as determined by research staff) 7. Already following a low-fat, vegan diet 8. Lack of English fluency 9. Inability to maintain current medication regimen 10. Inability or unwillingness to participate in all components of the study

Design outcomes

Primary

MeasureTime frameDescription
Migraines Pain Change in Migraines frequencyBaseline and 4 monthsPain as measured by VAS score
Change in Migraines frequencyBaseline and 4 monthsthe reduction in the number of migraine attacks.

Secondary

MeasureTime frameDescription
Quality of lifeBaseline and 4 monthsHealth related quality of life as measured by a questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026